Blog

  • True Partnership: Our Approach to Healthcare Innovation and Company Building

    NEA will invest more than $1.25B in healthcare companies in the next three years. Here's what you should know.  As a global, diversified VC firm with more than $20B in committed capital, we believe that size confers some distinct advantages. But after almost a decade as part of NEA’s healthcare practice, I’ve learned that our scale isn’t always well understood. The breadth of our activity can obfuscate the depth of our expertise. From the perspective of an…

  • Recent FDA Decisions Signal Shift, with Troubling Implications for Patients and Medical Innovation

    Drug development has always required a surfeit of intestinal fortitude. It can take hundreds of millions of dollars and a decade or more to bring a new drug to market, and each phase of development—from structuring a clinical trial to securing reimbursement from insurers—carries substantial risk. No entity plays a more central role in the process than U.S. Food and Drug Administration (FDA), which is charged with evaluating the safety and efficacy of new drugs, as well as determining…

  • Brandless:  Disrupting Everything in Consumer Packaged Goods

    “Make it simple, but significant.”  – Don Draper, Mad Men, 2010 I am excited to announce our recent investment in Brandless, a bold new consumer packaged goods (CPG) company that officially launched today.  Brandless’ mission is simple but significant: offer health-conscious products at a disruptively low price point that can’t easily be replicated by established CPG conglomerates.  Over the past several decades, consumers have grown to believe that…

  • Why Table Stakes Matter in Manufacturing Tech: Our Investment in Tulip

    Last summer, as a guest of a large industrial conglomerate, we took a week in steamy August to visit several factories—including power and lighting facilities in the Carolinas. We expected to see factories exemplary of the future manned by robots and fully automated with digital screens and wearable devices.  At NEA, we’ve invested in several companies that are relevant within these environments including Upskill, which offers a platform for leveraging wearables in the…

  • Deciphering the Current Wave of Cybersecurity Venture Capital

    The current wave of venture investing in cybersecurity took off in 2012, catalyzed by three major IPOs: Proofpoint, Splunk and Palo Alto Networks.  As is typical, big exits in a space significantly increase investor confidence and drive up supply of capital as additional investors rush in hoping to find the “next big thing.”      2013 saw another major exit with the “eye-popping” IPO of FireEye. It also became the year that cybersecurity…